Medpace
MEDP
464 hedge funds and large institutions have $5.78B invested in Medpace in 2023 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 168 increasing their positions, 148 reducing their positions, and 38 closing their positions.
129% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 38
66% more call options, than puts
Call options by funds: $21.2M | Put options by funds: $12.8M
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
23% more capital invested
Capital invested by funds: $4.68B → $5.78B (+$1.1B)
14% more repeat investments, than reductions
Existing positions increased: 168 | Existing positions reduced: 148
12% more funds holding
Funds holding: 416 → 464 (+48)
1.89% less ownership
Funds ownership: 81.08% → 79.19% (-1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$43.8M |
| 2 |
VRS
Virginia Retirement Systems
Richmond,
Virginia
|
+$34.9M |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
+$34.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.1M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$31.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$146M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$69.7M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$60.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41.2M |
| 5 |
ESCM
Echo Street Capital Management
New York
|
-$37.1M |
MEDP Hedge Fund Activity: Q2 2023 in Review
464 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2023, worth a combined $5.78B — up 23% from $4.68B a quarter earlier.
Buyers outnumbered sellers: 87 funds opened new MEDP positions and 38 closed out — a net gain of 49 holders — while 168 added to existing stakes and 148 trimmed.
The largest buyer was Riverbridge Partners, adding an estimated $43.8M. The largest seller was BlackRock, cutting an estimated $146M.
- 464 institutional investors held Medpace (MEDP) as of Q2 2023, up from 416 in Q1 2023.
- Funds reported $5.78B of Medpace stock for Q2 2023, up 23% quarter-over-quarter.
- 87 funds opened new Medpace positions in Q2 2023 and 38 closed out, a net change of +49 holders.
- The largest Medpace buyer in Q2 2023 was Riverbridge Partners, an estimated $43.8M added.
- The largest Medpace seller in Q2 2023 was BlackRock, an estimated $146M sold.
Based on aggregated 13F filings for Q2 2023.